NCD Trends
Chronic disease deaths decline globally, but progress is slowing
A landmark report shows mortality from chronic diseases fell in the decade preceding the COVID-19 pandemic (2010-2019), but progress has slowed.
Stories tagged with 'Cancer'
child leukaemia treatment
Modified CAR-iNKT therapy more effective in childhood leukaemia treatment
Scientists found that using two targets in CAR-iNKT therapy in mice can outperform standard treatments for high-risk childhood leukaemia.
Feature
Ultra modern medicine
Six things we learned about health innovation at Imperial Collider 2025
Experts from the life sciences industry have shared key insights into how healthcare innovation is changing and the next wave of medicines.
Cancer clusters
No increased risk of childhood cancer near UK nuclear sites, study finds
Children living near nuclear power stations in the UK are not at increased risk of childhood cancers, according to a new analysis.
1
Treating Ovarian Cancer
Consolidating Data on Ovarian Cancer into Stories
How Dr Laura Tookman and the iCARE Team Are Collaborating to Understand numbers on Ovarian Cancer
Reversing Ovarian Cancer
DNA’s hidden shape reveals target to reverse ovarian cancer chemoresistance
An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims over 200,000 lives globally each year
News in brief
Psychiatric drug development and an award for our Incubator: News from Imperial
Here’s a batch of fresh news and announcements from across Imperial.
B Cell Development
Ikaros and NuRD: A crucial partnership
New work has shown how a protein important in the development of B cells can repress target genes and regulate cell growth in leukaemia cells.
Cancer immune responses
New study paves way for immunotherapies tailored for childhood cancers
New research shows how children’s immune systems react differently to cancer than adult immune systems.
Zombie cell elimination
Inhibiting SMARCA4 powers the immune system to kill ‘zombie’ cancer cells
Scientists have developed a potential new approach for treating ovarian cancer by inhibiting a protein called SMARCA4.
